These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32026352)

  • 1. Effectiveness of pharmacist intervention model for chronic kidney disease patients; a prospective comparative study.
    Khokhar A; Khan YH; Mallhi TH; Khan HM; Alotaibi NH; Alzarea AI; Bokharee N
    Int J Clin Pharm; 2020 Apr; 42(2):625-634. PubMed ID: 32026352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
    Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
    BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Impact of a Pharmacist-Led Educational Campaign on Disease Knowledge, Practices and Medication Adherence for Type-2 Diabetic Patients: A Prospective Pre- and Post-Analysis.
    Khan YH; Alzarea AI; Alotaibi NH; Alatawi AD; Khokhar A; Alanazi AS; Butt MH; Alshehri AA; Alshehri S; Alatawi Y; Mallhi TH
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of pharmacist-led educational model in adult patients with allergic rhinitis: a single-center randomized control trial protocol (AR-PRISE RCT).
    Chew CC; Lim XJ; Letchumanan P; George D; Rajan P; Chong CP
    Trials; 2024 Apr; 25(1):279. PubMed ID: 38664701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice.
    Sarayani A; Mashayekhi M; Nosrati M; Jahangard-Rafsanjani Z; Javadi M; Saadat N; Najafi S; Gholami K
    Int J Clin Pharm; 2018 Apr; 40(2):345-353. PubMed ID: 29435911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Home medication management review in outpatients with chronic diseases in Jordan: a randomized control trial.
    Basheti IA; Al-Qudah RA; Obeidat NM; Bulatova NR
    Int J Clin Pharm; 2016 Apr; 38(2):404-13. PubMed ID: 26960406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist consultations in general practice clinics: the Pharmacists in Practice Study (PIPS).
    Tan EC; Stewart K; Elliott RA; George J
    Res Social Adm Pharm; 2014; 10(4):623-32. PubMed ID: 24095088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postdischarge community pharmacist-provided home services for patients after hospitalization for heart failure.
    Kalista T; Lemay V; Cohen L
    J Am Pharm Assoc (2003); 2015; 55(4):438-42. PubMed ID: 26161487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structured pharmacist-led intervention programme to improve medication adherence in COPD patients: A randomized controlled study.
    Abdulsalim S; Unnikrishnan MK; Manu MK; Alrasheedy AA; Godman B; Morisky DE
    Res Social Adm Pharm; 2018 Oct; 14(10):909-914. PubMed ID: 29104008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pharmaceutical care on health outcomes in patients with COPD.
    Jarab AS; Alqudah SG; Khdour M; Shamssain M; Mukattash TL
    Int J Clin Pharm; 2012 Feb; 34(1):53-62. PubMed ID: 22101426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Patients With CKD: A Subgroup Analysis of the Randomized Controlled R
    Al Hamarneh YN; Tsuyuki RT; Jones CA; Manns B; Tonelli M; Scott-Douglass N; Jindal K; Tink W; Hemmelgarn BR
    Am J Kidney Dis; 2018 Jan; 71(1):42-51. PubMed ID: 28912054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist impact on medication dosing and billable coding accuracy in outpatients with chronic kidney disease.
    Cypes IN; Prohaska ES; Melton BL
    J Am Pharm Assoc (2003); 2021; 61(2):e153-e158. PubMed ID: 33160871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of inpatient pharmaceutical care on nephrotic syndrome patients after discharge: a randomized controlled trial.
    Yin D; Guo Q; Geng X; Song Y; Song J; Wang S; Li X; Duan J
    Int J Clin Pharm; 2020 Apr; 42(2):617-624. PubMed ID: 32170589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of the Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) study.
    Schnipper JL; Roumie CL; Cawthon C; Businger A; Dalal AK; Mugalla I; Eden S; Jacobson TA; Rask KJ; Vaccarino V; Gandhi TK; Bates DW; Johnson DC; Labonville S; Gregory D; Kripalani S;
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):212-9. PubMed ID: 20233982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial.
    Lalonde L; Quintana-Bárcena P; Lord A; Bell R; Clément V; Daigneault AM; Legris MÈ; Letendre S; Mouchbahani M; Jouini G; Azar J; Martin É; Berbiche D; Beaulieu S; Beaunoyer S; Bertin É; Bouvrette M; Charbonneau-Séguin N; Desrochers JF; Desforges K; Dumoulin-Charette A; Dupuis S; El Bouchikhi M; Forget R; Guay M; Lemieux JP; Morin-Bélanger C; Noël I; Ricard S; Sauvé P; Ste-Marie Paradis F
    Am J Kidney Dis; 2017 Sep; 70(3):386-396. PubMed ID: 28663062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacist counseling improves outcomes for Taiwanese asthma patients.
    Wang KY; Chian CF; Lai HR; Tarn YH; Wu CP
    Pharm World Sci; 2010 Dec; 32(6):721-9. PubMed ID: 20798988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal pharmacists' perceptions and current practices of assessing medication adherence in dialysis patients.
    Ghimire S; Banks C; Jose MD; Castelino RL; Zaidi STR
    Int J Clin Pharm; 2018 Feb; 40(1):26-35. PubMed ID: 29214368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the implementability of clinical pharmacist interventions in patients with chronic kidney disease: an analysis of systematic reviews.
    Salgado TM; Correr CJ; Moles R; Benrimoj SI; Fernandez-Llimos F
    Ann Pharmacother; 2013 Nov; 47(11):1498-506. PubMed ID: 24259596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Process- and patient-reported outcomes of a multifaceted medication adherence intervention for hypertensive patients in secondary care.
    Hedegaard U; Hallas J; Ravn-Nielsen LV; Kjeldsen LJ
    Res Social Adm Pharm; 2016; 12(2):302-18. PubMed ID: 26088274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of pharmacist intervention in patients with chronic kidney disease.
    Cabello-Muriel A; Gascón-Cánovas JJ; Urbieta-Sanz E; Iniesta-Navalón C
    Int J Clin Pharm; 2014 Oct; 36(5):896-903. PubMed ID: 25135803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.